Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs.

ABSTRACT:

SUBMITTER: Ghorab A 

PROVIDER: S-EPMC9232594 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature